← Leaderboards
Michael Oertel
Albert Einstein College Of Medicine
$3,446,192
Attributed
$5,347,558
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,347,558 · 3
By mechanism
R01$5,347,558 · 3
Top collaborators
- Reben Raeman4 shared
- Mo Reza Ebrahimkhani2 shared
Most similar at Albert Einstein College Of Medicine
Same institution · by research overlap
- Chandan Guha$30,646,840
- Preeti Viswanathan$837,420
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesCellsFibrosisLiver FibrosisTissuesSenescenceMediatingLiverLiver DiseasesHepatocyteNovel Therapeutic InterventionIn VivoRattusAutomobile DrivingAnimal ModelGrowthActivin AIn VitroChronic Liver DiseaseCell AgingCell Cycle ArrestLiver TransplantationInvestigationHepatocyte Transplantation
Grant awards (11)
Combating Chronic Liver Diseases via Understanding and Engineering Cell Competition and Fitness$683,339
R01 · FY2025 · DK · contact PI
Combating Chronic Liver Diseases via Understanding and Engineering Cell Competition and Fitness$683,339
R01 · FY2024 · DK · contact PI
Blocking hepatocyte senescence as a novel therapeutic strategy for chronic liver diseases$595,568
R01 · FY2024 · DK · contact PI
Blocking hepatocyte senescence as a novel therapeutic strategy for chronic liver diseases$616,187
R01 · FY2023 · DK · contact PI
Blocking hepatocyte senescence as a novel therapeutic strategy for chronic liver diseases$616,187
R01 · FY2022 · DK · contact PI
Blocking hepatocyte senescence as a novel therapeutic strategy for chronic liver diseases$608,113
R01 · FY2021 · DK · contact PI
The role of activin A in mediating liver repopulation after cell transplantation$308,000
R01 · FY2015 · DK · contact PI
The role of activin A in mediating liver repopulation after cell transplantation$305,500
R01 · FY2014 · DK · contact PI
The role of activin A in mediating liver repopulation after cell transplantation$294,325
R01 · FY2013 · DK · contact PI
The role of activin A in mediating liver repopulation after cell transplantation$305,000
R01 · FY2012 · DK · contact PI
The role of activin A in mediating liver repopulation after cell transplantation$332,000
R01 · FY2011 · DK · contact PI